artificial intelligence

View All

artificial intelligence and covid-19
COVID-19 crisis can prove to be a catalyst for Artificial Intelligence in Healthcare

The novel coronavirus (COVID-19) within a span of five months, has infected around 1 million people, resulting in deaths of 50,000 people in over 180 countries around the world till date.  The major issue right now is containing its rapid transmission and effective treatment option. Apart from these issues,...

Find More

Artificial Intelligence
How Artificial Intelligence is adding value to the Healthcare sector

The word intelligence is derived from the Latin word intelligere, which means "to understand". In general terms, it is related to “one's ability to understand things” or “the capacity to acquire and apply knowledge and skills”. Intelligence can be broadly categorised into two forms, natural intelligence and art...

Find More

artificial intelligence
The Business Cocktail

Saama Technologies raises USD 40 Million to bolster AI Saama Technologies has got a hefty investment of USD 40million to accelerate its Artificial Intelligence and bolster its use in the branch of Life Sciences. This will help the California based data analytics company to innovate, curate and accelerate the cli...

Find More

artificial intelligence
Now, Artificial Intelligence to Accurately Identify Cancer Cells

In what could be regarded as a precursor to a new mode of cancer diagnosis, an artificial intelligence based tool, developed at the Osaka University in Japan, can precisely differentiate between different cancer cells, paving the way for automated determination of appropriate individualized cancer treatments. As a m...

Find More

FDA
Breakthrough Device Designation granted to the AI Software for CTEPH

[caption id="attachment_3727" align="aligncenter" width="2322"] FDA[/caption]

Find More

Novo Nordisk
Snippet

Novo Nordisk set to restructure R&D business Novo Nordisk, Danish drug maker, declared its plans to reorganise their R&D business, which include lay-off 400 workers of operations in Denmark and China. It is done so that the expansion is accelerated and its pipeline across serious chronic diseases is diversi...

Find More